News
SCHOTT Pharma has announced an investment of €100m ($114m) to expand its manufacturing capacity for sterile RTU cartridges.
During an FDA panel discussion, the US health secretary prioritised easier routes to market for curative therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback